Invicta Diagnostic IPO

About the company

Mumbai-based Invicta Diagnostic offers radiology and pathology testing services through its chain of diagnostic centers in Mumbai metropolitan region (MMR). The company operates under the brand name “PC Diagnostics”. It runs a hub-and-spoke network of 7 centres as of September 30, 2025, including 1 flagship facility, 3 hubs, and 3 spokes. The company offers a broad range of services: around 60 routine and 487 specialised pathology tests, plus 96 basic and 130 advanced radiology tests such as CT, MRI, and PET-CT. Radiology drives most of the business, contributing about 90.05% of revenue, followed by pathology at 9.95%. The customer mix is largely walk-in individual consumers, who make up 82.4% of revenue, while institutional accounts contribute the remaining 17.6% as of September 2025. All operations are concentrated within Mumbai, with centres in Thane–Sewri–Parel, Marol (Andheri East), Byculla, and Bhayander East. As of September 30, 2025, the company was running at an annualised pace of 336,927 tests between FY24 and H1FY26.

Financial performance (₹ Cr)

Subscription breakup (final, times)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   01 Dec 2025

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   03 Dec 2025

   Last day to place your bid

3. Basis of Allotment

   Completed
   04 Dec 2025

   Share allotment finalised

4. Refund Initiation

   Completed
   05 Dec 2025

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   05 Dec 2025

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   08 Dec 2025

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.